T regulatory cells (Treg) (CD4+ FoxP3+) and T helper (CD4+ FoxP3−) is significantly increased in ER mutant breast cancer, while CTLs had no difference, indicating the correction between ER and Treg differentiation [86]. This evidence concerns the gene FOXP3 and breast cancer.